PD-1 : PD-L2 [Biotinylated] Inhibitor Screening ELISA Kit

ユーザーレビュー
製品番号/仕様
価格
数量
EP-154-96tests
$770.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Materials Provided

    ID
    Components
    Size
    EP154-C01
    High-bind Plate
    1 plate
    EP154-C02
    Human PD-1
    15 μg
    EP154-C03
    Biotinylated Human PD-L2
    20 μg
    EP154-C04
    Anti-PD1 Neutralizing Antibody
    20 μg
    EP154-C05
    Streptavidin-HRP
    5 μg
    EP154-C06
    Coating Buffer
    12 mL
    EP154-C07
    10xWashing Buffer
    50 mL
    EP154-C08
    Blocking Buffer
    50 mL
    EP154-C09
    Substrate Solution
    12 mL
    EP154-C10
    Stop Solution
    7 mL

  • Product Overview

    PD-1 : PD-L2 [Biotinylated] Inhibitor Screening ELISA Kit is based on a competition-ELISA method, is used to screening for inhibitors of human PD-1 binding to human PD-L2. The kit is designed to provide a reliable solution for the screening of antibodies and small molecule inhibitors in the early stages, as well as QC release, to help researchers quickly screen and validate drugs, effectively improving research and development efficiency. It can also be used as a universal detection tool to identify the ability of human PD-1 binding to human PD-L2.

  • Reconstitution

    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

  • Storage

    Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Typical Data 

    Please refer to DS document for the assay protocol.

     PD-1 TYPICAL DATA

    INHIBITION OF PD-1: PD-L2 [Biotinylated] BINDING BY ANTI-PD-1 NEUTRALIZING ANTIBODY
    Serial dilutions of Anti-PD-1 Neutralizing antibody (Catalog # EP154-C04) (1:1 serial dilution, from 5 μg/mL to 0.0098μg/mL) was added into PD-1: Biotinylated PD-L2 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

ユーザーレビュー
コメントを投稿

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Programmed cell death protein 1

  • カテゴリ:

  • 市販の医薬品数:

    22 詳細

  • 治験医薬品数:

    193 詳細

  • 最新の開発ステージ:

    Approved

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8